Info
Insider Ownership

Insider Trading & Ownership of MICHAEL JOHN TOMSICEK

Location: Bedford, MA
Summary: The estimated net worth of MICHAEL JOHN TOMSICEK is at least $118,193 dollars as of 17 Jun 2025. MICHAEL JOHN TOMSICEK is the Chief Financial Officer of CRISPR Therapeutics AG and owns shares of CRISPR Therapeutics AG (CRSP) stock worth about $118.2K.
Signature: /s/ Adam D. Levy, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when MICHAEL JOHN TOMSICEK files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of MICHAEL JOHN TOMSICEK

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
CRSP	CRISPR Therapeutics AG	Chief Financial Officer	$118,193			06 Aug 2021
ACRV	Acrivon Therapeutics, Inc.	Director				13 Jun 2025
MIST	Milestone Pharmaceuticals Inc.	Director				10 Jun 2025

Insider Transactions Reported by MICHAEL JOHN TOMSICEK:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.